Drugmakers are making notable deals, biotech is coming back, and much of the worry about tariffs and interest rates has faded ...

According to an SEC filing dated November 14, 2025, Bain Capital Life Sciences Investors, LLC sold 122,106 shares of ...

The latest announcement is out from Sosei Group ( (JP:4565) ).

You've disabled cookies in your web browser. A third-party browser plugin, such as Ghostery or NoScript, is preventing ...

Olema OLMA stock fell 7% after-hours following announcement of a public offering of common stock and pre-funded warrants managed by TD Cowen.

Investing.com -- Agios Pharmaceuticals (NASDAQ:AGIO) stock fell 12% after the company announced mixed results from its Phase 3 RISE UP trial of mitapivat in sickle cell disease patients.

Experts predict short-term volatility due to global factors, though domestic fundamentals suggest potential medium-term gains ...

Olema Pharmaceuticals stock surged 197% after Roche reported positive trial results for a similar breast cancer drug.

Zentalis Pharmaceuticals, Inc. focuses on developing azenosertib with a pivotal Denali Phase 2 trial underway. Learn more ...

Lilly's tirzepatide is sold as Mounjaro for Type 2 diabetes and as Zepbound for weight loss -- but doctors have prescribed ...

Olema Pharmaceuticals, which trades on the Nasdaq under the ticker OLMA, is working to advance treatments for breast cancer through its development pipeline. The stock’s after-hours decline reflects ...

Bristol-Myers Squibb stands out in Big Pharma with strong sales growth and a solid dividend yield. Click here to read an ...